Home > Insider Trading > Filing (0001127602-12-014955)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1520262	Alkermes Plc.	ALKS	Pharmaceutical Preparations (2834)	981007018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236440	E Floyd Bloom	Connaught House 1 Burlington Road Dublin 4 Ireland		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-04-26	20,000	$17.59	90,281	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,028	Indirect	Floyd E Bloom Charitable Remainder Trust
Common Stock	21,066	Indirect	Jody Corey-Bloom Charitable Remainder Trust

Footnotes

The reporting person's purchase of Alkermes plc ordinary shares reported herein was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was inadvertently effected one day prior to the expiry of the six-month holding period mandated under Section 16(b) of the Securities Exchange Act of 1934. This purchase is matchable to the reporting person's sale of the same number of shares on October 28, 2011. The reporting person and Alkermes plc have entered into an agreement under which the reporting person has paid Alkermes plc the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.47 to $17.93. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.